Urgency For Approval Of OTC Naloxone In US Weighed Against Using Untested Package Labeling

All members of joint advisory panel noted urgent need to expand access to naloxone and voted yes on OTC sales of Emergent's Narcan nasal spray, but many also pointed out concerns for testing needed for DFl Facts label firm unveiled to the panel as well as to FDA officials during  meeting.